ANG Lifesciences India acquires Mansa Print & Publishers

ANG Lifesciences India, a fast-growing organisation with an ultra-modern fully integrated, manufacturing facility dedicated to dry powder injectables (SVP), has acquired the printing and packaging firm, Mansa Print & Publishers, which has undergone corporate insolvency resolution plan, as part of its strategic backward integration.

07 Apr 2021 | By PrintWeek Team

The ANG Lifesciences headquarters in Baddi

Located at Baddi in Himachal Pradesh, Mansa Print & Publishers is engaged in printing and packaging business covering manufacturing of packaging products, including cartons, corrugated boxes and aluminium foil.

Established in 2008, with its manufacturing facility in Baddi, ANG Lifesciences has a built-up area of 45,000-sqft, featuring cGMP pharmaceuticals manufacturing suite. The company is committed to quality products and services that address the prevention, diagnosis and treatment of diseases.

While it did not disclose the value of the acquisition, the company said in a regulatory filing that it acquired the Mansa infrastructure “at a very economical cost under Corporate Insolvency Resolution Plan.”

Explaining the reasons for the acquisition, the company said, “It is a strategic backward integration move for the company since it is expanding at a fast pace in the pharma segment. The packaging cost in formulation segment is almost 15-20% of the cost of product.”

It will be helpful for the company to optimise costs and ensure timely availability of packaging products for formulation business, the filing added.

“The acquisition holds a good potential for growth and profitability in the Baddi region, being a pharma hub,” it said.

(Courtesy: PTI)